Enhanced sulfamethoxazole degradation through ammonia oxidizing bacteria co-metabolism and fate of transformation products.

scientific article published on 15 February 2016

Enhanced sulfamethoxazole degradation through ammonia oxidizing bacteria co-metabolism and fate of transformation products. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.WATRES.2016.02.022
P698PubMed publication ID26938496

P50authorMaite PijuanQ47188916
Gianluigi ButtiglieriQ48509795
P2093author name stringLaura Ferrando-Climent
Ignasi Rodriguez-Roda
Elissavet Kassotaki
P2860cites workPharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissanceQ29617864
Effects on activated sludge bacterial community exposed to sulfamethoxazole.Q30637809
Antibacterial activity of sulfamethoxazole transformation products (TPs): general relevance for sulfonamide TPs modified at the para positionQ30850644
The link between nitrification and biotransformation of 17alpha-ethinylestradiolQ31118700
Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologiesQ33264630
Sorption and biodegradation of sulfonamide antibiotics by activated sludge: experimental assessment using batch data obtained under aerobic conditionsQ33885016
Polyclonal antibodies recognizing the AmoB protein of ammonia oxidizers of the beta-subclass of the class ProteobacteriaQ33988485
Evidence for the microbially mediated abiotic formation of reversible and non-reversible sulfamethoxazole transformation products during denitrification.Q34156574
Isolation of bacterial strains capable of sulfamethoxazole mineralization from an acclimated membrane bioreactorQ35665264
Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a reviewQ37359484
Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment--a reviewQ38009960
Biodegradation of sulfamethoxazole: current knowledge and perspectivesQ38035225
Insight into metabolic and cometabolic activities of autotrophic and heterotrophic microorganisms in the biodegradation of emerging trace organic contaminantsQ38129155
Pharmaceuticals as emerging contaminants and their removal from water. A review.Q38136419
A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatmentQ38176189
Ammonium removal by the oxygen-limited autotrophic nitrification-denitrification systemQ39563082
daime, a novel image analysis program for microbial ecology and biofilm researchQ39742703
Development of a common priority list of pharmaceuticals relevant for the water cycleQ40009494
Aerobic biodegradation of the sulfonamide antibiotic sulfamethoxazole by activated sludge applied as co-substrate and sole carbon and nitrogen sourceQ40106939
Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditionsQ43118472
Biodegradation potential of wastewater micropollutants by ammonia-oxidizing bacteriaQ43272931
The characteristics of enriched nitrifier culture in the degradation of selected pharmaceutically active compounds.Q43307525
Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes.Q43310489
Modelling cometabolic biotransformation of organic micropollutants in nitrifying reactors.Q43322050
Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatmentQ43323546
Occurrence of sulfonamide residues along the Ebro River basin: removal in wastewater treatment plants and environmental impact assessment.Q43324602
Impact of in-sewer transformation on 43 pharmaceuticals in a pressurized sewer under anaerobic conditions.Q43326390
Removal of PPCPs from the sludge supernatant in a one stage nitritation/anammox process.Q43326469
Irrigation of treated wastewater in Braunschweig, Germany: an option to remove pharmaceuticals and musk fragrancesQ43337667
Influence of nitrifying conditions on the biodegradation and sorption of emerging micropollutants.Q43347942
Microbial degradation of pharmaceuticals in estuarine and coastal seawaterQ43366414
Biodegradation of natural and synthetic estrogens by nitrifying activated sludge and ammonia-oxidizing bacterium Nitrosomonas europaea.Q44895677
Biodegradation and cometabolic modeling of selected beta blockers during ammonia oxidation.Q46230005
Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving watersQ46527216
Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in SwedenQ46556967
On the occasional biodegradation of pharmaceuticals in the activated sludge process: the example of the antibiotic sulfamethoxazole.Q46557001
N2O and NO emissions from a partial nitrification sequencing batch reactor: exploring dynamics, sources and minimization mechanismsQ48019619
Formation of diclofenac and sulfamethoxazole reversible transformation products in aquifer material under denitrifying conditions: batch experiments.Q51375137
Understanding the removal mechanisms of PPCPs and the influence of main technological parameters in anaerobic UASB and aerobic CAS reactors.Q53505572
Occurrence of drugs in German sewage treatment plants and riversQ56656254
Advanced mass spectrometric methods applied to the study of fate and removal of pharmaceuticals in wastewater treatmentQ57237725
Fate of sulfonamide antibiotics in contact with activated sludge – Sorption and biodegradationQ59625582
Evaluation of the Persistence of Micropollutants Through Pure-Oxygen Activated Sludge Nitrification and DenitrificationQ59808963
Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification schemeQ60691289
Occurrence and removal of pharmaceuticals and personal care products (PPCPs) in an advanced wastewater reclamation plantQ84817863
P407language of work or nameEnglishQ1860
P304page(s)111-119
P577publication date2016-02-15
P1433published inWater ResearchQ15708879
P1476titleEnhanced sulfamethoxazole degradation through ammonia oxidizing bacteria co-metabolism and fate of transformation products.
P478volume94

Reverse relations

cites work (P2860)
Q100514335A review of the biotransformations of priority pharmaceuticals in biological wastewater treatment processes
Q91161460Biotransformation of organic micropollutants by anaerobic sludge enzymes
Q90127921Co-metabolism of sulfamethoxazole by a freshwater microalga Chlorella pyrenoidosa
Q92273635Cometabolic biotransformation and microbial-mediated abiotic transformation of sulfonamides by three ammonia oxidizers
Q99358306Concentration dependent degradation of pharmaceuticals in WWTP effluent by biofilm reactors
Q47996470Degradation of emerging contaminants by acclimated activated sludge.
Q50804529Degradation of sulfonamides as a microbial resistance mechanism.
Q50196597Dye-sensitized TiO2-catalyzed photodegradation of sulfamethoxazole under blue or yellow light
Q93346465Free nitrous acid (FNA) induced transformation of sulfamethoxazole in the enriched nitrifying culture
Q43356814Impact of external carbon dose on the removal of micropollutants using methanol and ethanol in post-denitrifying Moving Bed Biofilm Reactors.
Q41693314Microbial technology with major potentials for the urgent environmental needs of the next decades
Q48031366Relative contribution of ammonia oxidizing bacteria and other members of nitrifying activated sludge communities to micropollutant biotransformation.
Q103044722Study of free nitrous acid (FNA)-based elimination of sulfamethoxazole: Kinetics, transformation pathways, and toxicity assessment
Q50905698Sulfamethoxazole degradation in anaerobic sulfate-reducing bacteria sludge system.
Q89730075Unravelling kinetic and microbial responses of enriched nitrifying sludge under long-term exposure of cephalexin and sulfadiazine

Search more.